Daicel Life Sciences

Daicel Life Sciences is a diversified technology company that provides solutions for the increasingly complex needs of the Pharmaceutical and related businesses. Among these capabilities is Duoflux™ EV an exosome isolation and purification system designed to process 5L of feed into 10mL of refined extracellular vesicles within hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method.

The company also offers Actranza® lab., an innovative needle-free device engineered for intracellular delivery of RNA and DNA vaccines without the need for needles, lipid nanoparticles (LNPs), or other carriers. Its performance is also showing promise across various other vaccination approaches and therapeutic modalities.

In addition, Daicel provides world-leading chiral chromatography products and services, which are routinely used in the development and large-scale manufacture of pharmaceutical ingredients, as well as Pharmaceutical Standards for identification and quantification of APIs, impurities, metabolites and degradation products.

www.daicel.com

Daicel USA - Expertise Partner - 8th Exosome-Based Therapeutic Development Summit
Daicel USA - Expertise Partner - 8th Exosome-Based Therapeutic Development Summit